This transcript explores the challenges faced by both physicians and patients in accessing treatment.

Professor Vogel discusses the differences in treatment access between Germany and Canada, having experienced both healthcare systems. He highlights the restrictive criteria for liver transplantation in Germany and the limited availability of certain therapies in Canada, particularly for rare cancers like cholangiocarcinoma. The discussion delves into the ethical implications of withholding potentially life-saving treatments and the need for a more streamlined and patient-centered approach to reimbursement. Financial toxicity is also examined, as well as the role of patient advocacy in driving change and ensuring timely access to treatment.

The transcript concludes with a call to action for patients and healthcare professionals to advocate for improved access to the right treatment at the right time.